Diebold Nixdorf DBD Gain (Loss) on Sale of Assets and Asset Impairment Charges
Gain (Loss) on Sale of Assets and Asset Impairment Charges at other companies
Other financials
Where this comes from
Reported directly by Diebold Nixdorf in its filing.
Tagged under the XBRL concept us-gaap:GainLossOnSalesOfAssetsAndAssetImpairmentCharges.
The official record: Diebold Nixdorf’s 10-K, filed February 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Diebold Nixdorf's gain (loss) on sale of assets and asset impairment charges.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Diebold Nixdorf's gain (loss) on sale of assets and asset impairment charges?
- Diebold Nixdorf (DBD) reported gain (loss) on sale of assets and asset impairment charges of $0 in Q4 2025.
- How has Diebold Nixdorf's gain (loss) on sale of assets and asset impairment charges changed year-over-year?
- Diebold Nixdorf's gain (loss) on sale of assets and asset impairment charges increased by 100.0% year-over-year, from -$175K to $0.
- What is the long-term trend for Diebold Nixdorf's gain (loss) on sale of assets and asset impairment charges?
- Over 2 years (2022 to 2025), Diebold Nixdorf's gain (loss) on sale of assets and asset impairment charges has grown at a -100.0% compound annual growth rate (CAGR), from -$106.7M to $0.
- What does gain (loss) on sale of assets and asset impairment charges mean?
- This metric represents the net financial impact of disposing of long-lived assets or recognizing write-downs due to impairment. It reflects management's ability to optimize the asset base and the potential obsolescence of hardware or software technologies within the portfolio. Investors use this to distinguish between core operational performance and non-recurring charges related to asset management.